Intrauterine Devices Market Report 2026

Intrauterine Devices Market Overview

• Intrauterine Devices market size has reached to $4.14 billion in 2025 • Expected to grow to $5.08 billion in 2030 at a compound annual growth rate (CAGR) of 4.2% • Growth Driver: Empowering Women In The Workforce Fuels Intrauterine Devices Market Growth • Market Trend: Cooper Surgical Launches Intuitive Single-Hand IUD Inserter to Simplify Procedures • North America was the largest region in 2025.

What Is Covered Under Intrauterine Devices Market?

Intrauterine devices refer to small, T-shaped contraceptive devices that are inserted into the uterus to prevent pregnancy. These devices provide a highly effective and long-lasting method of birth control. It works by altering the uterine environment to make it less conducive for sperm to fertilize an egg and, in some cases, affecting the uterine lining to inhibit implantation. The main types of products in intrauterine devices are hormonal intrauterine devices and copper intrauterine devices. A hormonal intrauterine device, often referred to as a hormonal IUD, is a contraceptive device that is inserted into the uterus to prevent pregnancy. It is used by various age groups, such as 15–24 years, 25–34 years, 35–44 years, and above 44 years, and it includes a variety of end users such as hospitals, gynecology clinics, community healthcare and others.

What Is The Intrauterine Devices Market Growth Forecast?

The intrauterine devices market size is expected to see steady growth in the next few years. It will grow to $5.08 billion in 2030 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to increasing demand for low-maintenance contraceptive solutions, expansion of public health family planning programs, growing preference for hormone-regulated devices, increasing adoption across emerging economies, ongoing innovation in iud materials and designs. Major trends in the forecast period include increasing adoption of long-acting contraceptive devices, rising demand for hormonal iuds, growing preference for reversible birth control methods, expansion of copper-based non-hormonal options, enhanced focus on patient safety and comfort.

Global Intrauterine Devices Market Segmentation

1) By Product: Hormonal Intrauterine Device, Copper Intrauterine Device 2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, Above 44 Years 3) By End-User: Hospitals, Gynecology Clinics, Community Healthcare, Other End Users Subsegments: 1) By Hormonal Intrauterine Device: Levonorgestrel-Releasing IUD (e.g., Mirena, Kyleena, Skyla), Progestin-Based IUD 2) By Copper Intrauterine Device: Standard Copper IUD, Mini Copper IUD

What Is The Driver Of The Intrauterine Devices Market?

The increasing number of women in the workforce is expected to propel the growth of the intrauterine devices market going forward. Women in the workforce refers to the participation and presence of women in paid employment across various industries and professions. The increasing number of women in the workforce is driven by greater economic independence, as more women pursue careers, contributing to household income and expanding demand for professional and healthcare services. IUDs offer working women a low-maintenance and highly effective contraceptive option, providing long-term protection against unintended pregnancies. For instance, in April 2025, according to the National Association of Home Builders, a US-based trade organization, as of March 2025, the rate remains stable at 57.5%, with women accounting for nearly 47% of the overall U.S. workforce. Therefore, the increasing number of women in the workforce is driving the growth of the intrauterine devices industry.

Key Players In The Global Intrauterine Devices Market

Major companies operating in the intrauterine devices market are Bayer AG, CooperSurgical Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Pregna International Limited, Medicines360 Inc, Eurogine S L, SMB Corporation, HLL Lifecare Limited, Injeflex Industria E Commercio Ltd, Corporate Channels India Pvt Ltd, Meril Endo Surgery Pvt Ltd, Krishco Medical Products Pvt Ltd, Prosan International BV, Gima Spa, Laboratoire HRA Pharma SAS, Shandong Weigao Medical Group Co Ltd, Chongqing Zhifei Biological Products Co Ltd, Yantai JiShengYaoXie Co Ltd, TianYi (China based IUD maker), Sebela Pharmaceuticals Inc, Fuji Latex Co Ltd

Global Intrauterine Devices Market Trends and Insights

Major companies operating in the intrauterine devices (IUD) market are focusing on product innovation, such as single-hand IUD insertion delivery systems, which streamline device placement, enhance provider ergonomics, and improve procedural efficiency without compromising contraceptive reliability. Single-hand IUD insertion delivery systems integrate a built-in loading mechanism and simplified deployment controls, enabling clinicians to insert the device with greater precision, reduced procedural steps, and improved ease-of-use in busy clinical settings. For instance, in September 2024, CooperSurgical, a US-based women’s health and medical device company, launched its new FDA-approved single-hand inserter for the Paragard intrauterine copper contraceptive. The redesigned inserter features an intuitive, single-hand mechanism with an integrated loading tip that simplifies placement while maintaining Paragard’s established benefits of over 99% efficacy, 10-year duration, hormone-free contraception, and immediate reversibility.

What Are Latest Mergers And Acquisitions In The Intrauterine Devices Market?

In November 2023, Bayer AG, a Germany-based life sciences and pharmaceutical company, entered into a development and option-to-license agreement with CrossBay Medical Inc. for an undisclosed amount. With this partnership, Bayer aims to advance and commercialize a next-generation single-handed intrauterine system (IUS) inserter by integrating CrossGlide technology to improve insertion comfort, reduce procedure time, and enhance the overall IUS placement experience. CrossBay Medical Inc. is a US-based medical device company specializing in innovative intrauterine insertion technologies.

Regional Outlook

North America was the largest region in the intrauterine devices market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Intrauterine Devices Market?

The intrauterine device market consists of sales of T-shaped frames, frameless IUDs, insertion devices, IUD removal kits, and monofilament strings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.